Ibrin side effects by duration, gender and age - a phase IV clinical study of FDA data
Summary:
Side effects are reported by people who take Ibrin. Common side effects include drug ineffective among females and appetite disorder among males.
The phase IV clinical study is created by eHealthMe based on 437 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
437 people who take Ibrin and have side effects are studied.
What is Ibrin?
Ibrin has active ingredients of fibrinogen, i-125. eHealthMe is studying from 439 Ibrin users for its effectiveness, alternative drugs and more.
Number of Ibrin reports submitted per year:
Ibrin side effects by time on the drug *:
Ibrin side effects by gender *:
Ibrin side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Ibrin?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on fibrinogen, i-125 (the active ingredients of Ibrin) and Ibrin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies
Alternative drugs to, pros and cons of Ibrin:
- Ibrin (439 reports)
All Ibrin side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Daptomycin and Toxic Neuropathy - now
- Miralax and Generalised Erythema - 4 seconds ago
- Cathflo Activase and Glucosamine drug interaction - 12 seconds ago
- Omeprazole and Hepatic Embolisation - 18 seconds ago
- Novalgin and Cervical Myelopathy - 21 seconds ago
- Selzentry and Niaspan drug interaction - 23 seconds ago
- Pantoprazole Sodium and Gastric Ulcer - 29 seconds ago
- Codeine and Pericarditis - 32 seconds ago
- Pepcid Ac and Rickets - 38 seconds ago
- Hydrocodone Bitartrate And Acetaminophen and Arnuity Ellipta drug interaction - 40 seconds ago